Mucosal approaches to HIV vaccine development.
Forrest
B D
BD
Department of Medical Microbiology, Royal Free Hospital School of Medicine, London, England.
D016915:AIDS Vaccines / Q000008:administration & dosage*; D005260:Female; D005836:Genitalia, Female / Q000276:immunology; D012739:Gonadal Steroid Hormones / Q000502:physiology; D015658:HIV Infections / Q000453:epidemiology / Q000517:prevention & control* / Q000628:therapy / Q000635:transmission; D015528:HIV Seroprevalence; D006801:Humans; D007071:Immunoglobulin A, Secretory / Q000276:immunology; D016233:Immunotherapy, Active; D008297:Male; D009092:Mucous Membrane / Q000166:cytology / Q000276:immunology; D012725:Sexual Behavior; D013601:T-Lymphocytes / Q000276:immunology; D006113:United Kingdom / Q000453:epidemiology; D014611:Vaccination / Q000379:methods*
D016915:AIDS Vaccines; D012739:Gonadal Steroid Hormones; D007071:Immunoglobulin A, Secretory